Addendum: Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge

PDF  |  How to cite

Oncotarget. 2023; 14:788-788. https://doi.org/10.18632/oncotarget.28483

Metrics: PDF 104 views  |   ?  

Silvana Ebner1, Ria Winkelmann1, Saskia Martin1, Jens Köllermann1, Peter J. Wild1,2, and Melanie Demes1,2

1Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany
2Wildlab, University Hospital MVZ GmbH, Frankfurt am Main, Germany

Published: August 30, 2023

Copyright: © 2023 Ebner et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: No external funding was obtained.

Original article: Oncotarget. 2022; 13:464-475. DOI: https://doi.org/10.18632/oncotarget.28213.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 28483